Philip L. Molyneaux
Guy's And St Thomas' NHS Trust
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 196 publications
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF.
Journal: Science translational medicine
Published: June 03, 2026
Nalbuphine for Cough Caused by Idiopathic Pulmonary Fibrosis-Reply.
Journal: JAMA
Published: May 28, 2026
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.
Journal: American journal of respiratory and critical care medicine
Published: March 02, 2026
Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease.
Journal: American journal of respiratory and critical care medicine
Published: February 28, 2026
Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study.
Journal: Nature communications
Published: February 27, 2026
Contribution of dominant and recessive model effects to the genetic architecture of Idiopathic Pulmonary Fibrosis.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2026
Prioritizing Therapeutic Targets for Interstitial Lung Disease: A Causal Mediation Analysis.
Journal: Research square
Published: February 12, 2026
Genes, gut microbiome and lungs: untangling the web of idiopathic pulmonary fibrosis.
Journal: ERJ open research
Published: February 11, 2026
Inhaled LTI-03 for Idiopathic Pulmonary Fibrosis: A Randomized Dose Escalation Study.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Find your career: the ERS "My Career Path" series.
Journal: Breathe (Sheffield, England)
Published: November 20, 2025
Last Updated: 09/26/2026